logo
Japan PM's wife Yoshiko Ishiba participates in International Yoga Day celebrations

Japan PM's wife Yoshiko Ishiba participates in International Yoga Day celebrations

Times of Oman21-06-2025
Tokyo: The Indian Embassy in Japan celebrated the International Day of Yoga, with the participation of more than 2000 yoga enthusiasts. Japan Prime Minister Shigeru Ishiba's wife, Yoshiko Ishiba, inaugurated the event and performed yoga.
Japan Foreign Minister Takeshi Iwaya's wife, Satoko Iwaya, also attended the event.
India's Ambassador to Japan, Sibi George, addressed the gathering of more than 2000 yoga enthusiasts. The Indian Embassy said that senior government officials, resident ambassadors, diplomats and friends of India in Japan attended the event.
In a post on X, the Indian Embassy in Japan stated, "Glimpses of the 11th International Day of Yoga 2025 in Tokyo! Inaugurated by Madam Yoshiko Ishiba, Spouse of Hon'ble PM of Japan. Occasion was graced by Madam Satoko Iwaya, Spouse of the Hon'ble Foreign Minister. Ambassador @AmbSibiGeorge addressed the gathering of over two thousand yoga enthusiasts. Also, marked by presence of Reverend Myoken Hayama & Reverend Tomohiro Kimura of Tsukiji Hongwanji, Spouse of Ambassador Madam Joice Sibi, senior government officials, Resident Ambassadors and diplomats and friends of India in Japan."
Every year, the 11th International Day of Yoga (IDY) is celebrated on June 21. This year marks the 11th International Day of Yoga with the theme "Yoga for One Earth, One Health", which echoes a vital truth that personal wellness and planetary health are inseparably linked.
Prime Minister Narendra Modi on Saturday took part in the 11th International Day of Yoga celebrations, where he hailed yoga as a gift "beyond age" that transcends all boundaries and unites humanity in "health and harmony."
The event took place against the scenic backdrop of the Visakhapatnam coastline, with Indian Navy ships stationed near the shore, adding to the grandeur of the celebrations. Over three lakh individuals joined him for a mass yoga session in the coastal city, reinforcing this year's message that 'yoga belongs to everyone' and brings the world together.
According to a United Nations statement, yoga strengthens the body, calms the mind, and fosters a heightened sense of awareness and responsibility in daily life. This mindfulness allows one to choose healthier and more sustainable lifestyles.
In 2014, the United Nations declared June 21 as the International Day of Yoga by resolution 69/131. The draft resolution establishing the International Day of Yoga was proposed by India and endorsed by a record 175 member states. PM Modi first introduced the proposal in his address during the opening of the 69th session of the General Assembly.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Philippines accelerates TB elimination drive with India's community-based screening devices
Philippines accelerates TB elimination drive with India's community-based screening devices

Times of Oman

time6 days ago

  • Times of Oman

Philippines accelerates TB elimination drive with India's community-based screening devices

New Delhi: The Philippines, one of the top five countries with the highest tuberculosis (TB) burden, faces the challenge of detecting and treating an estimated 1,90,000 missed TB cases each year, an official statement said. In line with the United Nations target to find and treat 2.1 million Tuberculosis cases in the country by 2027, the Philippines' Health Department is stepping up its commitment to strengthen community-level screening and diagnosis through India-made innovative Truenat® systems and ultra-portable X-ray devices. Currently, there are 68 Truenat® devices deployed across the Philippines, enabling rapid, multi-disease molecular testing for TB, HIV, HPV, Hepatitis B & C, and more. A pilot in the Bantayan Islands demonstrated the transformative potential of the platform, achieving a remarkable 1008% increase in TB case detection, as per the statement. Molbio's WHO-endorsed and ICMR-approved solutions for TB detection address critical barriers in the Philippines, such as geographic isolation, underutilization of laboratory testing, and limited access in rural and island communities. The recent approval of the PRORAD Atlas Ultraportable X-ray by the Philippines FDA paves the way for integrated, end-to-end TB screening and diagnosis, ensuring immediate linkage to treatment. Health Secretary of the Philippines Theodore J Herbosa said, "As we intensify our efforts to combat tuberculosis (TB) in the Philippines, the collaboration with India stands as a beacon of innovation and partnership. The integration of India's indigenous diagnostic technologies, such as the Truenat® system, into our healthcare infrastructure is pivotal. Truenat®, known for its rapid and reliable molecular diagnostic capabilities, allows for swift and accurate TB screenings, enhancing our capacity to manage and eventually eliminate TB within our borders, especially in remote areas." "This collaboration is part of a broader strengthening bilateral relationship between India and the Philippines, which now exceeds USD 3 billion in trade. India is a key supplier of pharmaceuticals, medical equipment, and diagnostic technologies, contributing significantly to our healthcare advancements. Our partnership with India is a prime example of how collaboration in health, technology, trade and defence can come together to address pressing challenges and enhance our bilateral ties, driving both healthcare progress and economic prosperity in our nations," added Theodore. As part of its ongoing commitment to the Philippines, Molbio Diagnostics will host a high-impact panel at the 31st Philippine Coalition Against Tuberculosis (PhilCAT) Annual Convention on August 14-15, 2025, in Manila. With a portfolio spanning more than 40 tests for infectious and non-infectious diseases, Molbio combines portability, speed, and accuracy to strengthen public health systems worldwide. Molbio's ongoing studies include a multi-country project funded by the R2D2 TB Network that is exploring novel tongue swab-based molecular diagnostics to improve TB detection among children and people living with HIV/AIDS, the statement said. "By bringing testing closer to communities--whether on remote islands or underserved rural areas--we can close the gap in TB detection and treatment, helping the Philippines achieve its elimination targets. We are committed to strengthening the fight against infectious diseases across the globe, helping countries build more resilient and responsive health systems," said Shiva Sriram, President of Molbio Diagnostics.

Japan: Two boxers die from brain injuries at Tokyo event
Japan: Two boxers die from brain injuries at Tokyo event

Times of Oman

time10-08-2025

  • Times of Oman

Japan: Two boxers die from brain injuries at Tokyo event

Tokyo: Two Japanese boxers have died within days of each other after sustaining brain injuries in separate bouts on the same fight card. The World Boxing Federation on Saturday confirmed the deaths, which occurred at Tokyo's iconic Korakuen Hall on August 2. The deaths have reignited urgent debate over boxing safety regulations in Japan — especially the duration of fights and ringside medical protocols. What do we know about the boxers' deaths? Shigetoshi Kotari, 28, collapsed shortly after completing a grueling 12-round tie against junior lightweight champion Yamato Hata on August 2. He was rushed into emergency surgery for a subdural hematoma, also known as a brain hemorrhage — a life-threatening condition where blood pools between the brain and skull — but died on Friday. The World Boxing Council confirmed Kotari's death was directly linked to injuries sustained during the bout. Just one day later, Hiromasa Urakawa, also 28, died after suffering the same type of brain injury during a knockout loss to Yoji Saito. The lightweight fighter was knocked out in the eighth and final round and underwent a craniotomy in a bid to save his life. Tributes paid to boxing 'warrior' The World Boxing Organisation (WBO) paid tribute to Kotari on social media. "The boxing world mourns the tragic passing of Japanese fighter Shigetoshi Kotari, who succumbed to injuries sustained during his August 2nd title fight," the statement said. "A warrior in the ring. A fighter in spirit. Gone too soon." Kotari's gym also released a heartfelt statement on its website: "He gave everything — fighting through surgery and treatment at a Tokyo hospital after suffering an acute subdural hematoma. He never stopped battling." Following Urakawa's death, the WBO issued a separate message extending its "deepest condolences to the families, friends, and the Japanese boxing community, during this incredibly difficult time." How has Japan's boxing regulator responded? Tsuyoshi Yasukochi, secretary-general of the Japan Boxing Commission (JBC), told local media on Saturday that it was likely "the first time in Japan two fighters underwent skull-opening surgery for injuries stemming from the same event." In response, the JBC announced that all Oriental and Pacific Boxing Federation title bouts will now be shortened from 12 rounds to 10. Urakawa's death marks the third boxing fatality worldwide from in-ring injuries this year. Last year, Irish boxer John Cooney died a week after being hospitalized following his Celtic super-featherweight title defeat to Nathan Howells in Belfast. He had suffered a severe brain injury during the bout. Calls for tighter oversight of boxing — both in Japan and internationally — have been gaining momentum following the fatalities.

Pharma businesses ready with contingency plans faced with US tariffs: Association of Healthcare Providers (India)
Pharma businesses ready with contingency plans faced with US tariffs: Association of Healthcare Providers (India)

Times of Oman

time01-08-2025

  • Times of Oman

Pharma businesses ready with contingency plans faced with US tariffs: Association of Healthcare Providers (India)

New Delhi: Indian pharmaceutical manufacturers are preparing a two-pronged strategy to offset the impact of the soon-to-be-effective 25 per cent US tariff on Indian goods, which includes drug exports, with industry experts anticipating that the move could significantly raise medicine costs in the American market. Girdhar Gyani, Director General of the Association of Healthcare Providers (India), has voiced concern over the financial burden the proposed US tariff would impose on both Indian exporters and American consumers. India currently supplies around 47 per cent of the US pharmaceutical market, largely in the form of affordable generics. "If the United States enforces this 25 per cent tariff, the cost of drug delivery in the US will inevitably rise. Our estimates show that American drug prices could increase by 20 to 25 per cent annually -- a burden of nearly USD 6 to USD 7 billion. It's unclear whether the US healthcare system can absorb such an impact," Gyani said. According to its website, the Association of Healthcare Providers (India) , a non-profit organisation, represents the majority of healthcare providers in India. Despite the initial blow to Indian manufacturers, Gyani stated that industry players are already preparing contingency plans. One such measure is ramping up production in US-based and Mexico-based facilities owned by Indian firms, which, according to Gyani, would bypass the tariff restrictions. "The second approach involves a shift in focus from basic generics to value-added combination drugs. These combination drugs, which offer the convenience of two medicines in one, can be priced higher despite having similar production costs," he noted. The goal is to increase the volume and price range of such drugs, thereby maintaining competitiveness even under the new tariff regime. Gyani also suggested that continued diplomatic engagement between New Delhi and Washington could help mitigate the situation. "Negotiations between the two governments are likely to continue, and we may eventually see a reduction or reconsideration of the tariff policy," he said. The executive order signed by President Donald Trump on Thursday has imposed a flat 25 per cent tariff on all goods from India, with no product-level exemptions. The pharmaceutical sector has been a key pillar of India-US trade relations.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store